ACETASTAT Trademark

Trademark Overview

On Monday, February 22, 2021, a trademark application was filed for ACETASTAT with the United States Patent and Trademark Office. The USPTO has given the ACETASTAT trademark a serial number of 90539027. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Thursday, August 1, 2024. This trademark is owned by Acetaminophen Toxicity Diagnostics, LLC. The ACETASTAT trademark is filed in the Pharmaceutical Products category with the following description:

Medical diagnostic assays being a lateral flow assay to detect acetaminophen protein adducts in human serum for use in assessing and diagnosing acetaminophen toxicity in humans
acetastat

General Information

Serial Number90539027
Word MarkACETASTAT
Filing DateMonday, February 22, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateThursday, August 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 28, 2021

Trademark Statements

Goods and ServicesMedical diagnostic assays being a lateral flow assay to detect acetaminophen protein adducts in human serum for use in assessing and diagnosing acetaminophen toxicity in humans
Pseudo MarkACETA STAT

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, May 22, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAcetaminophen Toxicity Diagnostics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLittle Rock, AR 72202
Party NameAcetaminophen Toxicity Diagnostics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLittle Rock, AR 72202

Trademark Events

Event DateEvent Description
Saturday, May 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 25, 2021NEW APPLICATION ENTERED
Friday, September 24, 2021PRIORITY ACTION E-MAILED
Wednesday, September 15, 2021ASSIGNED TO EXAMINER
Friday, September 24, 2021PRIORITY ACTION WRITTEN
Friday, September 24, 2021NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, November 19, 2021EXAMINERS AMENDMENT E-MAILED
Friday, November 19, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, November 19, 2021EXAMINER'S AMENDMENT ENTERED
Friday, November 19, 2021EXAMINERS AMENDMENT -WRITTEN
Friday, November 19, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 8, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 28, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 28, 2021PUBLISHED FOR OPPOSITION
Tuesday, February 22, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 24, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 18, 2022SOU TEAS EXTENSION RECEIVED
Thursday, August 18, 2022SOU EXTENSION 1 FILED
Thursday, August 18, 2022SOU EXTENSION 1 GRANTED
Saturday, August 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 24, 2023SOU EXTENSION 2 FILED
Tuesday, January 24, 2023SOU EXTENSION 2 GRANTED
Friday, July 14, 2023SOU EXTENSION 3 FILED
Friday, July 14, 2023SOU TEAS EXTENSION RECEIVED
Friday, July 14, 2023SOU EXTENSION 3 GRANTED
Tuesday, February 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 23, 2023ASSIGNED TO EXAMINER
Friday, February 2, 2024SOU TEAS EXTENSION RECEIVED
Friday, February 2, 2024SOU EXTENSION 4 FILED
Friday, February 2, 2024SOU EXTENSION 4 GRANTED
Thursday, August 1, 2024SOU TEAS EXTENSION RECEIVED
Thursday, August 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 1, 2024SOU EXTENSION 5 FILED
Thursday, August 1, 2024SOU EXTENSION 5 GRANTED

Related Keywords

acetastat acetaminophen serum human adducts assessing diagnosing humans toxicity protein medical